Beta Amyloid

信号通路图

研究领域

抑制剂选择性比较

Beta Amyloid产品

所有产品 Beta Amyloid抑制剂(13)

目录号	产品描述	文献引用	实验数据
S2215	DAPT (GSI-IX) DAPT (GSI-IX)是一种新型γ-secretase抑制剂，抑制 Aβ产生，在HEK 293细胞中IC50为20 nM。DAPT可促进人类舌癌细胞的凋亡并调节自噬。	Cancer Cell, 2020, 13;37(1):104-122e12 Adv Healthc Mater, 2020, 9(6):e1901658 Cells, 2020, 9(2)	Western blotting showing increased unconjugated SUMO1 levels in Notch1 ΔE cells treated with 10 uM DAPT for 3 days. Tubulin was used as a loading control.
S1575	RO4929097 RO4929097是一种γ secretase抑制剂，无细胞试验中IC50为4 nM，抑制Aβ40和Notch的细胞加工，EC50分别为14 nM和5 nM。Phase 2。	Clin Cancer Res, 2020, 10.1158/1078-0432.CCR-19-3420 Theranostics, 2020, 10(6):2553-2570 Cells, 2020, 9(1)
S2660	MK-0752 MK-0752是一种适度有效的γ-secretase（γ-分泌酶）抑制剂，降低Aβ40产量，IC50为5 nM。Phase 1/2。	Cell Death Differ, 2018, 25(2):330-339 Neoplasia, 2018, 21(1):93-105 Proc Natl Acad Sci USA, 2017, 114(50):E10782-E10791	HES1 expression after treatment with clinically available GSIs R04929097, BMS-708163, LY450139, and MK-0752 as determined by qRT-PCR.
S1262	Avagacestat (BMS-708163) Avagacestat (BMS-708163)是口服生物有效的，选择性的γ-分泌酶抑制剂，作用于Aβ40和Aβ42时，IC50分别为0.3 nM和0.27 nM，比作用于Notch选择性高193倍。Phase 2。	Biochem Pharmacol, 2020, 175:113921 Cancer Cell, 2019, 36(1):68-83 Clin Cancer Res, 2019, 10.1158/1078-0432.CCR-19-2479	A panel of GICs lines was treated with various concentrations of γ secretase inhibitors BMS-708163. Cells were treated with increasing concentrations of γ secretase inhibitors in triplicate wells for 72 hours, and cell viability was assessed by CellTiter-Blue assay as described in Materials and Methods. The results shown are of a single experiment with three independent replicates cell viability was measured by CellTiter-Blue assay. The graph depicts cell viability at 72 hours. Cell viability in the vehicle control was considered as to be 100%.
S1528	LY2811376 LY2811376是第一个口服有效的，非肽类β-secretase(BACE1)抑制剂，IC50为239 nM-249 nM，可以减少Aβ分泌，EC50为300 nM，作用于BACE1比作用于BACE2选择性高10倍，比作用于其他天冬氨酸蛋白酶（包括Cathepsin D，胃蛋白酶和肾素）抑制效果高50倍以上。Phase 1。	Alzheimers Dement, 2019, 15(9):1183-1194 J Cell Biol, 2019, 218(2):644-663 Prog Neuropsychopharmacol Biol Psychiatry, 2019, 90:161-168
S2418^New	Frentizole Frentizole是一种新型 amyloid beta peptide (Abeta) 结合 alcohol dehydrogenase (ABAD) 相互作用的抑制剂，IC50为200μM。Frentizole是一种无毒的抗病毒和免疫抑制剂，临床上用于类风湿关节炎和系统性红斑狼疮。
S6733^New	Edonerpic maleate Edonerpic maleate是一种神经营养性因子，可抑制amyloid-β peptides (Aβ)。
S4261	EUK 134 EUK 134是一种合成的超氧化物歧化酶（SOD）/过氧化氢酶类似物，具有强效的抗氧化活性，且抑制β-amyloid（β-淀粉样蛋白）和相关的淀粉样纤维形成。	Nat Commun, 2020, 23;11(1):433
S4760	(2-Hydroxypropyl)-β-cyclodextrin (HP-β-CD) HP-β-cyclodextrin (HP-β-CD), a well-known sugar used in drug delivery, genetic vector, environmental protection and treatment of Niemann-Pick disease type C1 (NPC1), is an inhibitor of amyloid-β aggregation.	Oncotarget, 2015, 6(30):29497-512
S5101	Tabersonine hydrochloride Tabersonine, an ingredient extracted from the bean of Voacanga africana, is a potent inhibitor against Aβ(1−42) aggregation and toxicity.
S9087	Tenuifolin Tenuifolin, a secondary saponin isolated from hydrolysates of polygalasaponins, inhibits beta-amyloid synthesis in vitro and has nootropic activity in vivo via acetylcholine esterase inhibition and increases norepinephrine and dopamine production.
S3811	Ginsenoside Re Ginsenoside Re (Ginsenoside B2) 是三七的提取物、人参中的主要人参皂苷，属于20(S)-原人参三醇组 (protopanaxatriol group)。它具有多种体外和体内作用，包括血管舒张作用，抗氧化剂，抗高血脂和血管生成作用。Ginsenoside Re 会降低 β-amyloid protein (Aβ) 并通过抑制 JNK 和 NF-κB 起到抗炎的作用。
S3923	Ginsenoside Rg1 Ginsenoside Rg1 是人参的主要活性成分之一，被确定为原人参三醇型，对多种癌症具有药理作用，例如神经保护和抗肿瘤作用。Ginsenoside Rg1 可降低 cerebral Aβ 水平并减少 NF-κB 核转移。

目录号	产品描述	文献引用	实验数据
S2215	DAPT (GSI-IX) DAPT (GSI-IX)是一种新型γ-secretase抑制剂，抑制 Aβ产生，在HEK 293细胞中IC50为20 nM。DAPT可促进人类舌癌细胞的凋亡并调节自噬。	Cancer Cell,2020, 13;37(1):104-122e12 Adv Healthc Mater,2020, 9(6):e1901658 Cells,2020, 9(2)	Western blotting showing increased unconjugated SUMO1 levels in Notch1 ΔE cells treated with 10 uM DAPT for 3 days. Tubulin was used as a loading control.
S1575	RO4929097 RO4929097是一种γ secretase抑制剂，无细胞试验中IC50为4 nM，抑制Aβ40和Notch的细胞加工，EC50分别为14 nM和5 nM。Phase 2。	Clin Cancer Res,2020, 10.1158/1078-0432.CCR-19-3420 Theranostics,2020, 10(6):2553-2570 Cells,2020, 9(1)
S2660	MK-0752 MK-0752是一种适度有效的γ-secretase（γ-分泌酶）抑制剂，降低Aβ40产量，IC50为5 nM。Phase 1/2。	Cell Death Differ,2018, 25(2):330-339 Neoplasia,2018, 21(1):93-105 Proc Natl Acad Sci USA,2017, 114(50):E10782-E10791	HES1 expression after treatment with clinically available GSIs R04929097, BMS-708163, LY450139, and MK-0752 as determined by qRT-PCR.
S1262	Avagacestat (BMS-708163) Avagacestat (BMS-708163)是口服生物有效的，选择性的γ-分泌酶抑制剂，作用于Aβ40和Aβ42时，IC50分别为0.3 nM和0.27 nM，比作用于Notch选择性高193倍。Phase 2。	Biochem Pharmacol,2020, 175:113921 Cancer Cell,2019, 36(1):68-83 Clin Cancer Res,2019, 10.1158/1078-0432.CCR-19-2479	A panel of GICs lines was treated with various concentrations of γ secretase inhibitors BMS-708163. Cells were treated with increasing concentrations of γ secretase inhibitors in triplicate wells for 72 hours, and cell viability was assessed by CellTiter-Blue assay as described in Materials and Methods. The results shown are of a single experiment with three independent replicates cell viability was measured by CellTiter-Blue assay. The graph depicts cell viability at 72 hours. Cell viability in the vehicle control was considered as to be 100%.
S1528	LY2811376 LY2811376是第一个口服有效的，非肽类β-secretase(BACE1)抑制剂，IC50为239 nM-249 nM，可以减少Aβ分泌，EC50为300 nM，作用于BACE1比作用于BACE2选择性高10倍，比作用于其他天冬氨酸蛋白酶（包括Cathepsin D，胃蛋白酶和肾素）抑制效果高50倍以上。Phase 1。	Alzheimers Dement,2019, 15(9):1183-1194 J Cell Biol,2019, 218(2):644-663 Prog Neuropsychopharmacol Biol Psychiatry,2019, 90:161-168
S2418^New	Frentizole Frentizole是一种新型 amyloid beta peptide (Abeta) 结合 alcohol dehydrogenase (ABAD) 相互作用的抑制剂，IC50为200μM。Frentizole是一种无毒的抗病毒和免疫抑制剂，临床上用于类风湿关节炎和系统性红斑狼疮。
S6733^New	Edonerpic maleate Edonerpic maleate是一种神经营养性因子，可抑制amyloid-β peptides (Aβ)。
S4261	EUK 134 EUK 134是一种合成的超氧化物歧化酶（SOD）/过氧化氢酶类似物，具有强效的抗氧化活性，且抑制β-amyloid（β-淀粉样蛋白）和相关的淀粉样纤维形成。	Nat Commun,2020, 23;11(1):433
S4760	(2-Hydroxypropyl)-β-cyclodextrin (HP-β-CD) HP-β-cyclodextrin (HP-β-CD), a well-known sugar used in drug delivery, genetic vector, environmental protection and treatment of Niemann-Pick disease type C1 (NPC1), is an inhibitor of amyloid-β aggregation.	Oncotarget,2015, 6(30):29497-512
S5101	Tabersonine hydrochloride Tabersonine, an ingredient extracted from the bean of Voacanga africana, is a potent inhibitor against Aβ(1−42) aggregation and toxicity.
S9087	Tenuifolin Tenuifolin, a secondary saponin isolated from hydrolysates of polygalasaponins, inhibits beta-amyloid synthesis in vitro and has nootropic activity in vivo via acetylcholine esterase inhibition and increases norepinephrine and dopamine production.
S3811	Ginsenoside Re Ginsenoside Re (Ginsenoside B2) 是三七的提取物、人参中的主要人参皂苷，属于20(S)-原人参三醇组 (protopanaxatriol group)。它具有多种体外和体内作用，包括血管舒张作用，抗氧化剂，抗高血脂和血管生成作用。Ginsenoside Re 会降低 β-amyloid protein (Aβ) 并通过抑制 JNK 和 NF-κB 起到抗炎的作用。
S3923	Ginsenoside Rg1 Ginsenoside Rg1 是人参的主要活性成分之一，被确定为原人参三醇型，对多种癌症具有药理作用，例如神经保护和抗肿瘤作用。Ginsenoside Rg1 可降低 cerebral Aβ 水平并减少 NF-κB 核转移。